Immune Modulators and IVF

Stopped early

Conditions studied: In Vitro Fertilization

In brief

Exploring the immune mediators of early pregnancy prospectively may help to identify new early interventions that will increase the likelihood of success and help women make informed decisions regarding their pregnancies.

Key facts

Study ID

NCT02626702

Run by

Weill Medical College of Cornell University

People needed

500

Starts

2015-07-31

Expected to finish

2019-08-31

Last updated by the study team

2019-09-16

Who can join

Age: 18 and older, up to 44. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• All fresh transfers

You may not qualify if…

• PGD

Where it is running

• Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.